Understanding Today’s Puzzling U.S. Economy
Inflation is high. The GDP has shrunk. But the job market has never been better. The Washington Post's Damian Paletta helps make sense of the U.S. economy today.
Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.
Guests
- Gardiner Harris Science reporter for "The New York Times"
- Alan Goldhammer, PhD Associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Dr. Sidney Wolfe Director of the Health Research Group at Public Citizen; editor of WorstPills.org
- Rep. Rosa DeLauro U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
- William Hubbard Former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
Most Recent Shows
How The Housing Crisis Spread, And What Happens Now
From high mortgage rates to shortages that have spread coast to coast, New York Times reporter Emily Badger explains the roots -- and consequences of our country's broken housing system.
The Tuskegee Study, 50 Years Later
Fifty years after the Tuskegee study, Diane talks to Harvard's Evelynn Hammonds about the intersection of race and medicine in the United States, and the lessons from history that can help us understand health inequities today.
What’s Next In The Fight Over Abortion
Pills, the right to travel and fetal personhood laws -- Diane talks to Temple University Law School's Rachel Rebouché about what's next in the fight over abortion in the U.S.
Comments
comments powered by Disqus